1. K-State home
  2. »Lafene
  3. »Treatment of Attention Deficit Disorder

Lafene Health Center

Treatment of Attention Deficit Disorder (ADD) by Lafene Health Center Staff

The purpose of this policy is to accurately diagnose and provide appropriate medical treatment for ADD/ADHD while identifying potential comorbidities and reducing the risk of controlled substance abuse among the students at Kansas State University.

Students previously diagnosed and treated for ADD/ADHD by an outside medical provider may choose to be followed for their condition at Lafene Health Center while they are attending Kansas State University. Prior to the first appointment for medical management, the student with ADD/ADHD must have copies of his/her medical records sent to Lafene for a medical staff provider evaluation, to ensure that a clinical interview and appropriate testing have been completed.

Students who have never been diagnosed or treated for ADD/ADHD must have completed psychological testing and received a diagnosis of ADD/ADHD prior to consideration of medical management by a Lafene provider. Testing providers in Manhattan/Riley County have been provided a list of acceptable diagnostic measures that are required at Lafene. To protect a student’s privacy, a student may be asked to give permission for a Lafene medical staff member to speak with the testing provider, a parent or a legal guardian about the diagnosis. A signed release of information will be obtained before sharing of information occurs.

The comprehensive diagnostic evaluation shall include the following components:

1. Clinical interview to include developmental history and assessment of the impact the student’s symptoms have on current school performance, occupational and relationship functioning.

2. Assessment of attention, concentration, distractibility and short-term memory.

3. Assessment for presence of other psychiatric disorders and substance abuse.

4. Medical examination including any appropriate laboratory tests (to be conducted by a Lafene provider).

We can provide a list of resources available for the appropriate testing. The cost of the testing will be at the student’s expense and may or may not be covered by his/her health plan/insurance. It will be the responsibility of the student to determine if the testing is covered by insurance or not, and if he/she wants to incur the associated charges. The following should be considered as requirements for psychological tests:

Assessment instruments for ADD/ADHD (two or more of the following):

• Brown Attention Deficit Disorder Scales – Adult

• CNS Vital Signs Neurocognitive Test

• Conner’s Adult ADHD Rating Scale (CAARS) Patient + one other informant

• Conner’s Continuous Performance Test (CPT III)

• Test of Variables of Attention (TOVA-A/TOVA-R)

• Visual and Auditory CPT (IVA-2)

• Barkley Adult ADHD Rating Scale –IV (BAARS-IV)

The following testing can be completed if the testing provider deems that it is indicated for the individual and it would be beneficial to ensure that he/she receives appropriate treatment.

Cognitive/Intellectual Testing (at the discretion of the testing provider):

• Kaufman Adolescent and Adult Intelligence Test (KAIT)

• Stanford-Binet-5 (SBS-5)

• Wechsler Adult Intelligence Scale (WAIS-IV)

• Woodcock-Johnson Tests of Cognitive Abilities (W-J IV)

Achievement/Academic Skills Testing (at the discretion of the testing provider):

• Wechsler Individual Achievement Test- adult norms (WIAT-III)

• Woodcock-Johnson-III: Tests of Academic Achievement

Personality Testing (at the discretion of the evaluator)

• Beck Anxiety Inventory (BAI)

• Beck Depression Inventory (BDI))

• Minnesota Multiphasic Personality Inventory (MMPI-2 or MMPI2RF)

Students will be asked to review and sign a Controlled Medication Agreement annually that outlines the conditions for treatment and steps that will be taken should any of the conditions of the agreement be violated.

Psycho-stimulant medications will not be provided to patients who are currently using, or dependent on controlled substances. Random drug screening may be conducted at any time.

Students will be advised not to share or sell their medication to others. If a provider has concerns of abuse or inappropriate use of the medication, dispensing can be discontinued at any time. No early refills will be honored.

Students will need to contact the Office of Student Access regarding academic accommodations.

A student who is being treated for ADD/ADHD must have a face to face clinic visit with the dispensing provider at least every three months. The dispensing provider may write up to a 90-day supply of medication at one time by issuing three separate 30 day prescriptions that include a “do not fill until (date)” or the student can be seen and receive a script at that time and may call in to the Lafene Pharmacy for 2 additional refills at one month intervals. For prescriptions filled at outside pharmacies the script can be left at the front desk for the student to pick up, or they can be mailed to the student if they have met the every three month visit criteria. Special considerations can be made for those students who are studying abroad for an extended period of time.

Student athletes should check with their trainer for NCAA compliance and ensure that they are set up with the learning specialist.

Current List of Screeners

Reviewed 1/16